Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384,317,619
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2,531,115
-
Shares change
-
-358,643
-
Total reported value, excl. options
-
$3,327,272
-
Value change
-
-$562,172
-
Number of buys
-
1
-
Number of sells
-
-6
-
Price
-
$1.32
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2023
13 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q2 2023.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,531,115 shares
of 384,317,619 outstanding shares and own 0.66% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,241,274 shares), Ikarian Capital, LLC (213,392 shares), KESTRA PRIVATE WEALTH SERVICES, LLC (31,241 shares), BOOTHBAY FUND MANAGEMENT, LLC (26,529 shares), GEODE CAPITAL MANAGEMENT, LLC (11,737 shares), RHUMBLINE ADVISERS (3,005 shares), OSAIC HOLDINGS, INC. (2,725 shares), Newbridge Financial Services Group, Inc. (1,100 shares), MORGAN STANLEY (100 shares), and UBS Group AG (12 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.